OncLive SOSS

Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia - Episode 4

Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL

July 5, 2023

Amanda Przespolewski, DO, Ibrahim Aldoss, MD

Dr Aldoss discusses the role ponatinib and blinatumomab in the management of Ph+ALL.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL

EP. 2: Evolving Standard of Care for Patients Diagnosed with Ph+ ALL

EP. 3: Recent Updates from the PhALLCON Study

EP. 4: Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL

EP. 5: Notable Advancements in Treatment for ALL

EP. 6: Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL

x